Vanderbilt's Neuroscience Unit Operates Like A Biotech
Executive Summary
A small drug-discovery shop within Vanderbilt University Medical Center shows how a focused approach can lead to top-notch results in the so-called translational research space.
You may also be interested in...
Sanford-Burnham Medical Research Institute: Making Sure New Drugs Aren't Lost In Translation
With a metabolic-disease deal with Takeda Pharmaceuticals already under its belt, Sanford Burnham aims to extend its academic prowess to more business-oriented opportunities. Chief Business Officer Paul Laikind, PhD, aims to inject entrepreneural blood into Sanford-Burnham's scientific muscle.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.